Entecavir/Pegylated Interferon in Immune Tolerant Children With Chronic Hepatitis B Virus (HBV) Infection
NCT01368497
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
60
Enrollment
NIH
Sponsor class
Conditions
Hepatitis B
Interventions
DRUG:
Entecavir and peginterferon
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)